Washington University School of Medicine in St. Louis received a $17 million grant from the National Institutes of Health to address disparities in cancer research, treatment and outcomes according to a Nov. 6 press release.
The research program, called the Washington University Participant Engagement and Cancer Genomic Sequencing Center, will focus on African American patients with colorectal cancer and multiple myeloma, as well as patients of any race or ethnicity with cholangiocarcinoma, a rare cancer of the bile ducts.
The program's goal is to fill gaps in knowledge to reduce the disparities seen in rare and understudied cancers that affect underrepresented groups.